These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6828551)

  • 1. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenics.
    Arató M; Bagdy G; Blümel F; Perényi A; Rihmer Z
    Pharmacopsychiatria; 1983 Jan; 16(1):19-22. PubMed ID: 6828551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum dopamine-beta-hydroxylase activity in schizophrenia.
    Meltzer HY; Nasr SJ; Tong C
    Biol Psychiatry; 1980 Oct; 15(5):781-8. PubMed ID: 6106516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The dopamine theory of schizophrenia: reduced serum dopamine beta hydroxylase activity in paranoid schizophrenia].
    Lipcsey A
    Orv Hetil; 1981 Feb; 122(8):483. PubMed ID: 7290692
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenia.
    Arató M; Bagdy G; Perényi A
    Biol Psychiatry; 1982 Jul; 17(7):853-4. PubMed ID: 6126229
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma dopamine-beta-hydroxylase in familial and sporadic paranoid schizophrenia.
    Markianos M; Rinieris P; Hatzimanolis J; Stefanis C
    Biol Psychiatry; 1990 May; 27(10):1176-8. PubMed ID: 2340326
    [No Abstract]   [Full Text] [Related]  

  • 7. [A study of plasma dopamine-beta-hydroxylase activity in patients with schizophrenia].
    Kuang PG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Nov; 15(4):193-7. PubMed ID: 7183426
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients.
    Meltzer HY; Cho HW; Carroll BJ; Russo P
    Arch Gen Psychiatry; 1976 May; 33(5):585-91. PubMed ID: 1267575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum dopamine-beta-hydroxylase activity in clinical subtypes of depression.
    Sapru MK; Rao BS; Channabasavanna SM
    Acta Psychiatr Scand; 1989 Nov; 80(5):474-8. PubMed ID: 2596346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The possible role of dopamine beta-monooxygenase in the pathogenesis of schizophrenia].
    Mailian KR; Boiadzhian AS; Melik-Pashaian MA; Aĭvazian VA; Karagezian KG
    Dokl Akad Nauk; 1995 Jun; 342(6):833-4. PubMed ID: 7580969
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma copper and dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Perlman R; Levitt M; Meltzer H; Gruen R; Asnis L
    Biol Psychiatry; 1982 Jan; 17(1):115-20. PubMed ID: 7059633
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative studies of various clinical and psychopharmacological parameters of schizoaffective psychosis and paranoid schizophrenia].
    Masiak M; Perzyński J; Nagay J; Marmurowska-Michałowska H; Olajossy M; Wysocka A
    Psychiatr Pol; 1990; 24(5):1-9. PubMed ID: 2131470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum dopamine-beta-hydroxylase activity and lateral ventricular size in affective disorders and schizophrenia.
    Meltzer HY; Tong C; Luchins DJ
    Biol Psychiatry; 1984 Oct; 19(10):1395-402. PubMed ID: 6335052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-beta-hydroxylase and its apparent endogenous inhibitory activity in the plasma of some psychiatric patients.
    Yu PH; O'Sullivan KS; Keegan D; Boulton AA
    Psychiatry Res; 1980 Oct; 3(2):205-10. PubMed ID: 6947313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on concentrations of NA and HVA and activity of DBH in the serum from schizophrenic patients, first-degree relatives and normal subjects.
    Wei J; Ramchand CN; Hemmings GP
    Schizophr Res; 1992 Dec; 8(2):103-10. PubMed ID: 1360811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Neuropsychobiology; 1982; 8(6):312-4. PubMed ID: 6131392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activities of brain dopamine-beta-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls.
    Cross AJ; Crow TJ; Killpack WS; Longden A; Owen F; Riley GJ
    Psychopharmacology (Berl); 1978 Oct; 59(2):117-21. PubMed ID: 103111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics and biochemistry of paranoid schizophrenia and other paranoid psychoses.
    Kendler KS; Davis KL
    Schizophr Bull; 1981; 7(4):689-709. PubMed ID: 7034192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine-beta-hydroxylase activity in serum and cerebrospinal fluid in neuropsychiatric diseases.
    Okada T; Ohta T; Shinoda T; Kato T; Ikuta K
    Neuropsychobiology; 1976; 2(2-3):139-44. PubMed ID: 1012449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are paranoid schizophrenics biologically different from other schizophrenics?
    Potkin SG; Cannon HE; Murphy DL; Wyatt RJ
    N Engl J Med; 1978 Jan; 298(2):61-6. PubMed ID: 619236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.